GE Healthcare Said to Weigh Selling Stake in China Business

GE Healthcare, a subsidiary of General Electric, is considering selling a portion of its China business operations, according to sources familiar with the matter. The move is part of GE's ongoing efforts to streamline its portfolio and focus on its core healthcare technology business. The potential stake sale in the China unit is still in the early stages, and the company is evaluating various options, including bringing in a strategic investor or finding a minority partner. The decision is driven by GE's desire to optimize its resources and capital allocation, as it looks to strengthen its position in the global healthcare market. The China market is a significant growth opportunity for GE Healthcare, and the company is exploring ways to leverage its expertise and brand to capitalize on the increasing demand for healthcare services in the country. The potential stake sale could provide GE with additional funds to invest in research and development, as well as to expand its presence in other key markets.